期刊名称：AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
2013 Impact Factor: 1.470
5-year Impact Factor: 1.807
Ranking: 65/111 (Psychology,Clinical), 18/34 (Substance Abuse)
14/18 (Substance Abuse SCIE)
© Thomson Reuters, Social Science Journal Citation Report® 2014
From Vol.40(2) the Journal is now indexed in the Science Journal Citation Report
Read More: http://informahealthcare.com/page/ada/Description
2013 Impact Factor: 1.470
5-year Impact Factor: 1.807
Ranking: 65/111 (Psychology,Clinical), 18/34 (Substance Abuse)
14/18 (Substance Abuse SCIE)
© Thomson Reuters, Social Science Journal Citation Report® 2014
From Vol.40(2) the Journal is now indexed in the Science Journal Citation Report
Read More: http://informahealthcare.com/page/ada/Description
2013 Impact Factor: 1.470
5-year Impact Factor: 1.807
Ranking: 65/111 (Psychology,Clinical), 18/34 (Substance Abuse)
14/18 (Substance Abuse SCIE)
© Thomson Reuters, Social Science Journal Citation Report® 2014
From Vol.40(2) the Journal is now indexed in the Science Journal Citation Report
Aims & Scope
The American Journal of Drug and Alcohol Abuse is an international journal now published six times per year and provides an important and stimulating venue for the exchange of ideas between the researchers working in diverse areas, including public policy, epidemiology, neurobiology, and the treatment of addictive disorders. The journal includes a wide range of translational research, covering preclinical and clinical aspects of the field. The Journal covers these topics with focused data presentations and authoritative reviews of timely developments in our field. Manuscripts exploring addictions other than substance use disorders are encouraged. Reviews and Perspectives of emerging fields are given priority consideration.
Areas of particular interest include:
- public health policy
- novel research methodologies
- human and animal pharmacology
- human translational studies, including neuroimaging
- pharmacological and behavioral treatments
- new modalities of care
- molecular and family genetic studies
- medicinal use of substances traditionally considered substances of abuse
Abstracting & Indexing
Indexed/Abstracted in:
Academic Search Complete, Biological Abstracts, Biomedical Reference Collection: Comprehensive, BIOSIS Previews, Consumer Health Complete, Current Contents®/Social and Behavioral Sciences, EMBASE, EMCARE, ETOH, Health and Safety Abstracts, Journal Citation Reports/ Social Sciences Edition, PASCAL, Popline, PsychInfo, PubMed/MedLine, Risk Abstracts, Social Sciences Citation Index®, Sociological Abstracts, Social SciSearch, Social Services Abstracts, SCOPUS
Instructions to Authors
To download a PDF version please click here
To submit a manuscript, please use our online submission system.
Please refer to Resources for Authors and Editors prior to submission.
Technical questions regarding submission should be addressed to the Editorial Assistant (Robbi Banks at (Ajdaa-EditorialAssistant@UTSouthwestern.edu).
Questions regarding the Journal’s potential interest in a manuscript should be addressed to the Editor (Bryon Adinoff, MD, at ajdaa-editor@utsouthwestern.edu).
Review Process
All manuscripts receive an initial review by the Journal Editor to determine the originality, validity, and importance of content and conclusions. A manuscript may be declined before peer-review if deemed out of scope or if it does not meet the general standards of the journal. All other manuscripts are sent for peer review. Authors will be sent reviewer comments that are judged to be useful to them. Authors are informed about the Editor’s decision after the review process is completed. The journal operates a double-blinded review process- all reviewers remain anonymous to the authors and the authors are not identified to the reviewers.
Submission of Manuscripts
Manuscripts should be submitted electronically via the journal's online submission system: http://mc.manuscriptcentral.com/lada.
In order to ensure a blind review process authors should prepare and upload two versions of their manuscript. The first version [“Main Document (unblinded)”] should be a complete text, including a title page and full declaration of interest statement. The second version [“Main document (no author identifying information)”] must not include any identifying information. All names (on both the title page and declaration of interest), affiliations, and addresses should be removed from the second version.
The author will be asked to acknowledge that the paper has not been published elsewhere and that it has not been submitted simultaneously for publication elsewhere. Authors are responsible for obtaining permission to reproduce copyrighted material from other sources and are required to sign an agreement for the transfer of copyright to the publisher. All accepted manuscripts, artwork, and photographs become the property of the publisher.
All parts of the manuscript should be typewritten, double-spaced, with margins of at least one inch on all sides. Number manuscript pages consecutively throughout the paper. A Declaration of Interests should be noted on the cover letter of all submitted manuscripts (see “Declaration of Interests” below).
Types of Articles
Title Page: The title page should be submitted as a separate file (Title Page) and should not be included in the manuscript file (Main Document). This will ensure that a double-blinded review can take place.
The title page should include:
- The complete manuscript title
- A running head title, not exceeding 50 character spaces.
- The full names of all authors and their affiliations
- Name and address for correspondence, including telephone number and e-mail address
- All sources of support, including pharmaceutical and industry support, that require acknowledgement
- In upper right hand corner, number of words, figures and tables. Word count includes only the main body of text (i.e., not tables, figures, abstracts or references).
Abstract: No more than 250 words organized under the following subheaders: Background, Objectives, Methods (include # of subjects), Results, Conclusion. Clinical trial registration numbers should be included in the abstract, with full details provided in the methods section. The Abstract must be included in the Main Document.
Perspective
Perspective articles may cover a wide variety of topics of current interest relevant to addictive disorders or the medicinal use of substances generally associated with substance use. The Journal will consider topics spanning the development and treatment of addictive disorders, including predisposing vulnerabilities, diagnosis, intervention and consequences and ranging from preclinical to service to policy research. Authors are encouraged to submit manuscripts that evoke discussion. Perspectives may be invited. Perspectives should not exceed 2,000 words and be limited to 20 references.
Review
Comprehensive reviews of the literature are encouraged. Preference will be given to reviews exploring emerging fields. Reviews should not exceed 5,000 words.
Original Article
Original articles should not exceed 4,000 words. Generally, we will consider a series of cases that illustrate an important clinical or research issue as a regular article. Discussions should address the translational application of the reported findings. This is particularly important for manuscripts addressing preclinical questions. When appropriate, this narrative should reflect how the presented findings promote the reduction of substance use and/or prevalence of substance use disorders via prevention, treatment, service delivery, or policy. Novel case reports and other uncontrolled observations should be submitted as Letters to the Editor.
Letters to the Editor
Brief letters (maximum of 500 words, including references) will be considered if they include a cover letter indicating that the correspondence is “for publication.” Case reports will be peer reviewed. Letters commenting on an article published in the Journal must be received within 3 months of the article’s print publication. Letters received after the deadline will not be considered for publication; those considered will be sent to the article’s corresponding author to reply on behalf of the group. Such letters must include the title and author of the article and the month and year of publication. Letters that do not meet these specifications will be returned unreviewed. Letters will be published on a space available basis.
Supplemental Information
Additional tables or figures can be submitted in a separate file as supplemental data for posting online.
Abbreviations
Only a very small number of abbreviations are considered “standard” and thus acceptable for use. Spell out all abbreviations (other than those for units of measure) the first time they are used; idiosyncratic abbreviations not generally known in the field should not be used.
Editing Resources
Authors for whom English is a second language may choose to have their manuscript professionally edited before submission or during the review process. Authors wishing to pursue a professional English-language editing service should make contact and arrange payment with the editing service of their choice. For more details regarding the recommended services, please refer to Resources for Authors and Editors.
References
References to cited literature should be identified by a numbered list at the end of the paper in order of appearance. Please cite in text with the number in parentheses.Endnote Users can use this template to prepare a manuscript.
Examples:
- Journal: Chung T, Langenbucher J, Labouvie E, Pandina RJ, Moos RH. Changes in alcoholic patients’ coping responses predict 12-month treatment outcomes. J Consult Clin Psychol 2001; 69(1):92-100.
- Book: Monti PM, Abrams DB, Kadden RM, Cooney NL. Treating Alcohol Dependence: A Coping Skills Training Guide. New York, NY: Guilford Press, 1989.
- Contribution to a Book: Pantalon MV, Schottenfeld RS, Monitoring therapist and patient behavior during behavioral interventions of illicit drug abuse: process research perspectives. In Contingency Management Interventions for Illicit Drug Abuse. Higgins S, Silverman K, eds. Washington, DC: American Psychological Association Books, 1999; 309-325.
Illustrations
Illustrations submitted (line drawings, halftones, photos, photomicrographs, etc.) should be clean originals or digital files. Digital files are recommended for highest quality reproduction.
- 300 dpi or higher
- Sized to fit on journal page
- EPS, TIFF, or PSD format only
- Submitted as separate files, not embedded in text files
Color illustrations will be considered for publication; however, the author will be required to bear the full cost involved in their printing and publication. The charge for the first page with color is $1000.00. The next three pages with color are $500.00 each. A custom quote will be provided for color art totaling more than 4 journal pages. Good-quality color prints should be provided in their final size. The publisher has the right to refuse publication of color prints deemed unacceptable.
Tables and Figures
Each complete figure (including titles and footnotes) should be understandable without reference to the text. Tables can be embedded in the text, but should be included after the main text and references. Figures should not be embedded in the text, but should be included in their original file formats as separate files. A short descriptive title should appear above each table with a clear legend and any footnotes suitably identified below. All units must be included. Figures should be completely labeled, taking into account necessary size reduction. Captions should be typed, double-spaced, on a separate sheet. All original figures should be clearly marked in pencil on the reverse side with the number, author’s name, and top edge indicated. If error bars are included, note whether standard deviations or standard errors of the mean are used.
Proofs
Page proofs are sent to the designated corresponding author. They must be carefully checked and returned within 48 hours of receipt. Please note that in the proof stage, only typographical errors, printer's errors and errors of scientific fact can be corrected. No substantial author's changes will be made.
Reprints
Each corresponding author of the article will receive a complete copy of the issue in which the article appears. Reprints of an individual article are available for order at the time authors review page proofs.
Editorial Policies
Declaration/ Conflict of Interest Statement
Copyright Transfer Agreement
Authorship, Submissions, Plagiarism and Peer Review
Ethics and Consent
Clinical Trials Registry
Copyright and Permissions
Proofs, Reprints and Colour Figures
CrossCheck
For more author resources, including NIH and Wellcome Trust policies, click here.
Contacting the Publisher
Managing Editor: Dawn Hunter
Production Editor: Simone Skeen
Informa Healthcare,
Christchurch Court,
10-15 Newgate Street,
London,
EC1A 7AZ
Instructions to Authors
The American Journal of Drug and Alcohol Abuse.pdf
Editorial Board
Editorial Advisory Board
Editor in Chief
Bryon Adinoff - VA North Texas Health Care System, University of Texas Southwestern Medical Center
Associate Editors
Ralph Tarter - University of Pittsburgh
Edythe D. London - University of California Los Angeles
Editorial Assistant
Robbi Banks - UT Southwestern Medical Center
Editorial Board:
Isabelle Boileau - University of Toronto
Kathleen Brady - Medical University of South Carolina
Domenic Ciraulo - Boston University
Karen Ersche – University of Cambridge
Francesca Filbey – University of Texas Dallas
Marc Galanter - New York University School of Medicine
David Gorelick - University of Maryland
Suchitra Krishnan-Sarin - Yale University School of Medicine
Paul J. Kenny - Icahn School of Medicine at Mt. Sinai
Lin Lu - Institute on Drug Dependence Peking University
Edward Nunes - Columbia University
Sakire Pogun - Ege University, Turkey
Uma Rao - Meharry Medical College and Vanderbilt University School of Medicine
Richard K. Ries - University of Washington
Marc I. Rosen - VA Connecticut Healthcare System, Yale University School of Medicine
Roger Weiss - Harvard University
Reinout W. Wiers - University of Amsterdam
|
刊名字顺( Alphabetical List of Journals):
返回页首 